Combined Hepatocellular-cholangiocarcinoma
Also known as: Combined Hepatocellular Cholangiocarcinoma / Cholangiocarcinoma; With Hepatocellular Carcinoma / Combined Hepatocellular and Cholangiocarcinoma / Hepatocellular Carcinoma , Cholangiocarcinoma / Combined Hepatocellular Carcinoma and Cholangiocarcinoma / Mixed hepatocellular cholangiocarcinoma / Combined hepatocellular carcinoma and cholangiocarcinoma (morphologic abnormality) / Combined hepatocellular carcinoma and cholangiocarcinoma (disorder)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11885 | Anlotinib | 1 / 2 | Not Yet Recruiting | 1 |
DB00441 | Gemcitabine | 1 / 2 | Not Yet Recruiting | 1 |
DB00526 | Oxaliplatin | 1 / 2 | Not Yet Recruiting | 1 |
DB15765 | Sintilimab | 1 / 2 | Not Yet Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Recruiting | 1 |
DB14547 | Chloride ion | 2 | Recruiting | 1 |
DB00515 | Cisplatin | 2 | Recruiting | 1 |
DB01394 | Colchicine | 2 | Recruiting | 1 |
DB14889 | Derazantinib | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Recruiting | 1 |
DB12257 | Platinum | 2 | Recruiting | 1 |